Avista reaches multi-party settlement in Idaho general rate

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
520
Avista reaches multi-party settlement in Idaho general rate cases

SPOKANE, Wash., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Avista (NYSE:AVA) and multiple parties to the company’s electric and natural gas general rate cases have reached a settlement agreement that has been submitted to the Idaho Public Utilities Commission (IPUC or Commission) for its consideration. If approved, new rates would take effect Jan. 1, 2018 and Jan. 1, 2019. 

If approved, the settlement agreement is designed to increase annual billed electric revenues by $12.9 million, or 5.6 percent, effective Jan. 1, 2018, and by $4.5 million, or 2.3 percent, effective Jan. 1, 2019. For natural gas, the settlement agreement is designed to increase annual billed revenues by $1.2 million, or 1.9 percent, effective Jan. 1, 2018, and by $1.1 million, or 1.8 percent on Jan. 1, 2019. The settlement revenue increases are based on a 9.5 percent return on equity (ROE) with a common equity ratio of 50 percent.

“This settlement agreement will provide new rates in Idaho that are fair and reasonable for our customers, the Company and our shareholders,” said Dennis Vermillion, Avista Corp. senior vice president and president of Avista Utilities. “This outcome provides us the opportunity to continue to earn a fair return in Idaho and supports Avista’s efforts to invest in and maintain our infrastructure so we can continue to provide the reliable energy our customers expect. In addition, the two-year rate plan would create a stay-out period where Avista would not file a new general rate case for a new rate plan to be effective prior to Jan. 1, 2020, providing customers with some predictability in their expected future energy prices.”

Residential Customer Electric Bills 2018 and 2019
If the settlement is approved, a residential electric customer using an average of 910 kilowatt hours per month would see:

  • A billed increase of $5.22 per month, or 5.9 percent, for a revised monthly bill of $93.34, effective Jan. 1, 2018. The total revised average monthly bill amount includes the effects of an increase in the basic charge of $0.25, from $5.75 to $6.00 per month.
  • A billed increase of $2.16 per month, or 2.3 percent, for a revised monthly bill of $95.50, effective Jan. 1, 2019. There would be no change to the basic charge for 2019 rates.

If approved, the electric billed increases by service schedule for 2018 are as follows:

Rate Schedule 2018 Billing Increase
Residential Service - Schedule 1 5.9%
General Service - Schedules 11 & 12 5.2%
Large General Service - Schedules 21 & 22 5.7%
Extra Large General Service - Schedule 25 4.7%
Extra Large General Service - Schedule 25P 4.8%
Pumping Service - Schedules 31 & 32 6.1%
Street & Area Lights - Schedules 41 – 49 5.1%
Overall 5.6 %

If approved, the electric billed increases by service schedule for 2019 are as follows:

Rate Schedule 2019 Billing Increase
Residential Service - Schedule 1 2.3%
General Service - Schedules 11 & 12 2.1%
Large General Service - Schedules 21 & 22 2.3%
Extra Large General Service - Schedule 25 2.2%
Extra Large General Service - Schedule 25P 2.2%
Pumping Service - Schedules 31 & 32 2.4%
Street & Area Lights - Schedules 41 – 49 1.9%
Overall 2.3 %

Residential Customer Natural Gas Bills 2018 and 2019
If the settlement is approved, a residential natural gas customer using an average of 63 therms per month would see:

  • A billed increase of $1.13 per month, or 2.1 percent, for a revised monthly bill of $53.74, effective Jan. 1, 2018. The total revised average monthly bill amount includes the effects of an increase in the basic charge of $0.75, from $5.25 to $6.00 per month.
  • A billed increase of $1.09 per month, or 2.0 percent, for a revised monthly bill of $54.83, effective Jan. 1, 2019. There would be no change to the basic charge for 2019 rates.

If approved, the natural gas billed increases by service schedule for 2018 are as follows:

Rate Schedule 2018 Billing Increase
General Service - Schedule 101 2.2%
Large General Service - Schedules 111 & 112 0.7%
Interruptible Service - Schedules 131 & 132 0.0%
Transportation Service - Schedule 146 3.0%
Special Contracts - Schedule 148 0.0%
Overall 1.9 %

If approved, the natural gas billed increases by service schedule for 2019 are as follows:

Rate Schedule 2019 Billing Increase
General Service - Schedule 101 2.1%
Large General Service - Schedules 111 & 112 0.7%
Interruptible Service - Schedules 131 & 132 0.0%
Transportation Service - Schedule 146 2.7%
Special Contracts - Schedule 148 0.0%
Overall 1.8 %

Avista serves more than 128,600 electric customers and 80,000 natural gas customers in Idaho.

Avista’s Original Request
Avista’s original request included an increase in annual electric billed revenues by $18.6 million or 7.9 percent, effective Jan. 1, 2018 and $9.9 million or 4.2 percent effective Jan. 1, 2019.

For natural gas, the rate request included an increase in annual billed revenues by $3.5 million or 5.7 percent, effective Jan. 1, 2018 and $2.1 million or 3.3 percent effective Jan. 1, 2019.

The electric and natural gas requests for the January 2018-December 2019 rate periods were based on a proposed rate of return (ROR) on rate base of 7.81 percent with a common equity ratio of 50 percent and a 9.9 percent return on equity (ROE).

Customer Resources
To assist customers in managing their energy bills, Avista offers services for customers such as comfort level billing, payment arrangements and Customer Assistance Referral and Evaluation Services (CARES), which provide assistance to special-needs customers through referrals to area agencies and churches for help with housing, utilities, medical assistance and other needs. Avista also partners with community action agencies in administering the Project Share bill payment assistance program.

Avista provides energy efficiency and outreach programs that include rebates and incentives as well as tips and resources to help customers manage their energy use and energy bills. Customers can learn more at www.myavista.com .

About Avista Corp.
Avista Corp. is an energy company involved in the production, transmission and distribution of energy as well as other energy-related businesses. Avista Utilities is our operating division that provides electric service to 378,000 customers and natural gas to 342,000 customers. Its service territory covers 30,000 square miles in eastern Washington, northern Idaho and parts of southern and eastern Oregon, with a population of 1.6 million. Alaska Energy and Resources Company is an Avista subsidiary that provides retail electric service in the city and borough of Juneau, Alaska, through its subsidiary Alaska Electric Light and Power Company . Avista stock is traded under the ticker symbol "AVA."  For more information about Avista, please visit www.avistacorp.com .

This news release contains forward-looking statements regarding the company’s current expectations. Forward-looking statements are all statements other than historical facts. Such statements speak only as of the date of the news release and are subject to a variety of risks and uncertainties, many of which are beyond the company’s control, which could cause actual results to differ materially from the expectations. These risks and uncertainties include, in addition to those discussed herein, all of the factors discussed in the company’s Annual Report on Form 10-K for the year ended Dec. 31, 2016 and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2017.

SOURCE: Avista Corporation

-1772-

To unsubscribe from Avista’s news release distribution, send a reply message to lena.funston@avistacorp.com   

Contact:                                                                                                         
Media: Debbie Simock (509) 495-8031, debbie.simock@avistacorp.com
Investors: Lauren Pendergraft (509) 495-2998, lauren.pendergraft@avistacorp.com
Avista 24/7 Media Access (509) 495-4174    

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

IONQ Achieves Record Stock Levels Amid Strong Growth Indicators

Updated Category News Views 243

IONQ Stock Reaches New Heights Recently, IONQ has made headlines as its stock skyrocketed to an unprecedented level of $47.41, marking a significant achievement for the company. With a robust market capitalization of $10.2 billion, this remarkable performance is a testament to the company's impressive growth trajectory and the strong belief investors hold in its future....

Continue Reading
Model 1 Commercial Vehicles Expands Leadership Team for Growth

Updated Category News Views 285

Model 1 Commercial Vehicles Announces Leadership Changes Model 1 Commercial Vehicles is thrilled to unveil a set of key leadership appointments aimed at enhancing its strategic direction and ensuring the company's ongoing success. These changes reflect the impressive growth trajectory the company has experienced over the past few years. Tony Matijevich Takes the Helm as...

Continue Reading
Texas Instruments: Unusual Options Trends Uncovered

Updated Category News Views 195

Texas Instruments Options Insights Financial powerhouses have made a notable bullish move on Texas Instruments. Our analysis reveals intriguing trends within the options market for Texas Instruments (NASDAQ: TXN), showcasing an unusual number of trades that pinpoint shifting market sentiments. Trading Sentiment Overview Diving deeper into the data, it appears that 58% of...

Continue Reading
SMCP Unveils Latest Interim Financial Report for 2025

Updated Category News Views 177

SMCP Announces Availability of Its Interim Financial Report SMCP is excited to share that its interim financial report for the six-month period ending June 30, 2025, is now available for public access. This report has been officially filed with the relevant regulatory authorities. Details on the Financial Report This financial report outlines the company's performance...

Continue Reading
Kevin O'Leary Discusses Business Leaders' Support for Trump

Updated Category News Views 159

Understanding O'Leary's Perspective on Business Leadership Kevin O’Leary, a prominent entrepreneur and investor from Shark Tank, has provided insight into the evolving relationship between business leaders and President Trump. In recent discussions, O’Leary emphasized that the admiration many tech CEOs and corporate leaders have for Trump is not solely about his tax...

Continue Reading